Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 28, 2021

Primary Completion Date

April 5, 2024

Study Completion Date

April 5, 2024

Conditions

Melanoma and Vitiligo

Interventions

OTHER

Biospecimen into patients who had skin diseases

Collect of blood samples without DNA into patients who had a vitiligo or a melanoma at day 0 until 1 year after their treatment

Trial Locations (1)

CHU de Nice, Nice

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT04920162 - Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma | Biotech Hunter | Biotech Hunter